65,437 trials
Alopecia Areata
Primary: Percentage of Participants Achieving Severity of Alopecia Tool (SALT) ≤ 20 - Phase 3 — 5.3; 21.7; 35.2 percentage of participants — p=<0.001
Youth
Primary: Healthy Partner Relationship Behavior Measurement #1 — 2.93; 2.97 score on scale
Neoplasms
Primary: Maximum Tolerated Dose (MTD) — 720 Milligram
Health
Primary: ΔT at the Waist Between 30 Minutes and the Baseline. — 0.71; 0.42; 0.43; 0.49 ℃
Breast Cancer
Primary: Number of Participants With Disease Recurrence One Year After the Intervention. — 1 Participants
COVID-19 · Vaccinations
Primary: Number of Subjects Ever Tested — 70; 58 Participants
Fathers
Primary: Healthy Parenting Behavior Measurement #1 — 3.93; 4.26 score on scale
Fathers
Primary: Healthy Parenting Behavior Measurement #1 — 3.67; 4.10 score on scale
PE - Pulmonary Embolism · PE - Pulmonary Thromboembolism
Primary: Subjects With Major Adverse Events — 24; 964 Participants
Breast Cancer
Primary: Pre-operative Concentration of NT-proBNP — 38.9; 32.2 pg/ml — p=0.714
Spinal Muscular Atrophy
Primary: Number of Participants With Adverse Events (AEs) — 12; 76; 70; 14 Participants
Smoking Cessation
Primary: Stress as Assessed by a Visual Analog Scale (VAS) for Stress — 3.4; 3 score on a scale
Age-Related Macular Degeneration · Genetic Testing · Nutritional Biomarkers
Primary: Change in Skin Carotenoid Status in Response to Genetic Risk Disclosure as Measured by Reflectance Spectroscopy — 257.7; 290.9 Reflection units (RU)
Healthy Volunteers, Adolescent
Primary: Performance of the PureWick System in Adolescents After HCP Placement and Self-placement — 90.40; 93.09; 87.15; 90.41 Percentage of urine captured
Fathers
Primary: 1) Healthy Parenting Behaviors Measurement #1 — 3.92; 3.97 score on scale